You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Letairis

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Exercise-induced Pulmonary Arterial Hypertension Trial in Boston (Ambrisentan)

Completed
Has Results
  • Exercise-induced Pulmonary Arterial Hypertension
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 5, 2022

COVID-19 Trial in Cambridge (EDP1815, Dapagliflozin, Ambrisentan)

Recruiting
  • COVID-19
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Jun 9, 2021

Pre-Pulmonary Atrial Hypertension Trial in Denver (Ambrisentan)

Terminated
  • Pre-Pulmonary Atrial Hypertension
  • Denver, Colorado
    National Jewish Health
Jan 15, 2021

Portopulmonary Hypertension Trial in United States (Ambrisentan)

Completed
Has Results
  • Portopulmonary Hypertension
  • La Jolla, California
  • +5 more
Dec 16, 2020

Systemic Sclerosis, Shortness of Breath, Pulmonary Hypertension Trial in Los Angeles (Ambrisentan)

Completed
Has Results
  • Systemic Sclerosis
  • +2 more
  • Los Angeles, California
    David Geffen School of Medicine, University of California, Los A
Oct 28, 2020

Pharmacogenomics in Pulmonary Arterial Hypertension

Withdrawn
  • Pulmonary Arterial Hypertension
  • +2 more
  • Pittsburgh, Pennsylvania
    Allegheny General Hospital
Nov 29, 2021

Sickle Cell Anemia Trial in Augusta (Ambrisentan, Placebo)

Completed
  • Sickle Cell Anemia
  • Augusta, Georgia
    Augusta University
Apr 1, 2020

Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction Trial in Dallas (Ambrisentan, Placebo)

Terminated
Has Results
  • Pulmonary Hypertension
  • Heart Failure With Preserved Ejection Fraction
  • Dallas, Texas
    UT Southwestern Medical Center
May 15, 2020

Pulmonary Arterial Hypertension Trial in Boston (Ambrisentan plus Spironolactone, Ambrisentan plus Placebo)

Terminated
Has Results
  • Pulmonary Arterial Hypertension
  • Ambrisentan plus Spironolactone
  • Ambrisentan plus Placebo
  • Boston, Massachusetts
    Brigham & Women's Hospital
Nov 13, 2019

Pulmonary Arterial Hypertension Trial in New Orleans, Charleston (Ambrisentan)

Terminated
Has Results
  • Pulmonary Arterial Hypertension
  • New Orleans, Louisiana
  • +1 more
Apr 5, 2019

Side Effects of Pulmonary Hypertension Medications

Completed
  • Pulmonary Hypertension
    • Stanford, California
      Lucile Packard Children's Hospital at Stanford
    Sep 15, 2021

    Sarcoidosis, Pulmonary Hypertension Trial in Chapel Hill, Charleston (Ambrisentan)

    Completed
    • Sarcoidosis
    • Pulmonary Hypertension
    • Chapel Hill, North Carolina
    • +1 more
    Jul 31, 2018

    Hypertension, Pulmonary Trial in Worldwide (Ambrisentan)

    Active, not recruiting
    • Hypertension, Pulmonary
    • Aurora, Colorado
    • +21 more
    Apr 7, 2022

    Pulmonary Hypertension Trial in Worldwide (Ambrisentan)

    Completed
    Has Results
    • Pulmonary Hypertension
    • Birmingham, Alabama
    • +45 more
    Sep 8, 2020

    Portopulmonary Hypertension, Pulmonary Hypertension, Cirrhosis, Liver Trial in New Orleans (Ambrisentan Pill, Tadalafil Pill)

    Withdrawn
    • Portopulmonary Hypertension
    • +2 more
    • Ambrisentan Pill
    • Tadalafil Pill
    • New Orleans, Louisiana
      Ochsner Clinic Foundation
    Dec 5, 2018

    Systemic Sclerosis, Scleroderma Trial in Philadelphia (Ambrisentan)

    Completed
    Has Results
    • Systemic Sclerosis
    • Scleroderma
    • Philadelphia, Pennsylvania
      University of Pennsylvania Health System
    Nov 26, 2018

    Pulmonary Arterial Hypertension, Systemic Sclerosis, Scleroderma Spectrum of Diseases Trial in Baltimore (tadalafil and

    Completed
    Has Results
    • Pulmonary Arterial Hypertension
    • +4 more
    • tadalafil and ambrisentan upfront combination therapy
    • Baltimore, Maryland
      Johns Hopkins University
    Aug 11, 2017

    Hypertension, Pulmonary Trial in Worldwide (Ambrisentan - low dose, Ambrisentan - high dose)

    Terminated
    Has Results
    • Hypertension, Pulmonary
    • Ambrisentan - low dose
    • Ambrisentan - high dose
    • Aurora, Colorado
    • +23 more
    Sep 19, 2019

    n Ulcer, Scleroderma, Systemic Trial in Stanford (Ambrisentan)

    Completed
    Has Results
    • n Ulcer
    • Scleroderma, Systemic
    • Stanford, California
      Stanford University School of Medicine
    Mar 1, 2017

    Acute Mountain Sickness and Fatigue Trial in Durham (Aminophylline 400 mg, Ambrisentan 5 mg, Placebo)

    Completed
    • Acute Mountain Sickness and Fatigue
    • Aminophylline 400 mg
    • +2 more
    • Durham, North Carolina
    • +1 more
    Nov 11, 2015

    Pulmonary Arterial Hypertension Trial in Boston (CT imaging, functional PET imaging)

    Withdrawn
    • Pulmonary Arterial Hypertension
    • CT imaging, functional PET imaging
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 10, 2016

    Respiratory Tract AEs in Patients Treated With Tyvaso® Compared

    Completed
    Has Results
    • Pulmonary Arterial Hypertension
    • inhaled prostacyclin
    • +4 more
    • Birmingham, Alabama
    • +87 more
    Jan 20, 2016

    Pulmonary Arterial Hypertension Trial in Birmingham (ambrisentan)

    Completed
    Has Results
    • Pulmonary Arterial Hypertension
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jul 17, 2014

    High Altitude Pulmonary Hypertension Trial in Durham (Aminophylline, Ambrisentan, Aminophylline plus ambrisentan)

    Completed
    Has Results
    • High Altitude Pulmonary Hypertension
    • Durham, North Carolina
      Duke Clinical Research Unit
    Nov 28, 2013

    Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension Trial in Worldwide (Ambrisentan, Placebo)

    Terminated
    Has Results
    • Idiopathic Pulmonary Fibrosis
    • Pulmonary Hypertension
    • Birmingham, Alabama
    • +84 more
    May 5, 2014